GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Abingdon Health PLC (OTCPK:ABDXF) » Definitions » Cash, Cash Equivalents, Marketable Securities

Abingdon Health (Abingdon Health) Cash, Cash Equivalents, Marketable Securities : $2.53 Mil (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Abingdon Health Cash, Cash Equivalents, Marketable Securities?

Abingdon Health's quarterly cash, cash equivalents, marketable securities declined from Dec. 2022 ($5.42 Mil) to Jun. 2023 ($4.09 Mil) but then stayed the same from Jun. 2023 ($4.09 Mil) to Dec. 2023 ($2.53 Mil).

Abingdon Health's annual cash, cash equivalents, marketable securities declined from Jun. 2021 ($6.98 Mil) to Jun. 2022 ($2.95 Mil) but then increased from Jun. 2022 ($2.95 Mil) to Jun. 2023 ($4.09 Mil).


Abingdon Health Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for Abingdon Health's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abingdon Health Cash, Cash Equivalents, Marketable Securities Chart

Abingdon Health Annual Data
Trend Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cash, Cash Equivalents, Marketable Securities
Get a 7-Day Free Trial 1.10 5.49 6.98 2.95 4.09

Abingdon Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Cash, Cash Equivalents, Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.93 2.95 5.42 4.09 2.53

Abingdon Health Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.


Abingdon Health  (OTCPK:ABDXF) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.


Abingdon Health Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of Abingdon Health's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.


Abingdon Health (Abingdon Health) Business Description

Industry
Traded in Other Exchanges
Address
York Biotech Campus, Sand Hutton, York, GBR, YO41 1LZ
Abingdon Health PLC is a technology-enabled lateral flow diagnostics company. It provides rapid testing solutions to clients in healthcare and other industries. The firm's product ABC-19 is an antibody test for Covid-19 , and also produces tests covering areas such as self-test HIV, equine infection, human fertility, etc. Business operating segments includes; Contract Development comprises development work for third parties. Contract Manufacturing comprises contract development and manufacturing activities. Product Sales comprises the sale of ABC-19, Pocket Diagnostic products, PCRD tests and antibodies for research use. Key revenue comes from Contract Development segment. Geographically it operates and earns revenue from the UK, USA and Canada, Europe and the rest of the world.

Abingdon Health (Abingdon Health) Headlines

From GuruFocus

AbC-19� Rapid Test Available for Purchase by Healthcare Professionals

By Business Wire Business Wire 02-16-2021